Biodefence Market Scope And Analysis

  • Report Code : TIPRE00005377
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Biodefense Market Scope and Key Players - 2031

Buy Now


Biodefense Market Report Scope

Report Attribute Details
Market size in 2021 US$ 12.37 Billion
Market Size by 2031 US$ 21.62 Billion
Global CAGR (2023 - 2031) 6.1%
Historical Data 2021-2023
Forecast period 2024-2031
Segments Covered By Product
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation
  • Nuclear
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bavarian Nordic
  • Alnylam Pharmaceuticals Inc
  • SIGA Technologies
  • Emergent BioSolutions Inc
  • Cleveland Bio Labs
  • Dynavax Technologies
  • Elusys Therapeutics Inc
  • Soligenix
  • Altimmune
  • Pluristem